NLRP3 and metabolic dysfunction-associated steatohepatitis: Later, in an animal model of NASH, significantly reduced liver inflammation with attenuated expression of TLR4 and NLRP3 has been reported in Gal-3-deficient mice in comparison to Gal-3-expressing mice [135].